Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Regarding the current need in predictive persisting models for Mycobacterium abscessus, we adopted the classical assay for studying drug-tolerant bacterial persisters, focusing on the behavior of a small mycobacterial antibiotic-insensitive subpopulation during prolonged exposure to moxifloxacin. Our study showed a widely ranging response of M. abscessus depending on the antibiotic concentration, the growth stage of mycobacterial cultures, and the availability of potassium ions in the medium. Middle logarithmic cultures, which were initially grown in the balanced or K + -free medium, contained small sup-populations to be competent for prolonged and stable survival in the presence of moxifloxacin. The response of mid-log cultures to the antibiotic attack involved killing with further re-growth upon exposure to 1 -2 MBCs of moxifloxacin or profound elimination of antibiotic insensitive subpopulation to < 10 2 CFU/mL in the presence of moxifloxacin at 16 MBCs. A stage when the number of viable survived cells was constant occurred for stationary-phase cultures grown in the complete medium and exposed to high moxifloxacin dose. On the contrary, antibiotic insensitive subpopulations in stationary-phase M. abscessus cultures that faced potassium deficiency underwent gradual killing during exposure to moxifloxacin in a wide concentration range (1 -16 MBCs). Electron microscopy studies demonstrated that singular cells were rapidly destructed after relatively short-term exposure to moxifloxacin, unlike cells in aggregates or clumps which disappeared afterwards and provided an explanation for the delayed biocidal effect. A small subpopulation that survived under harsh moxifloxacin pressure was remarkably heterogenous in cell morphology and fine structure and was composed of ovoid forms and cell-wall deficient cells with reduced size. The obtained results predict a possibility of distinct effects from the same antibiotic dose on M. abscessus cells depending on their physiological state and abundance in an infected cell or tissue. Taken together, our study may contribute to the development of strategies for combatting recalcitrant survivor subpopulations.

Blotch Detection Based on Texture Matching and Adaptive Multi-threshold

In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin Against Klebsiella Pneumoniae in a Neutropenic Murine Lung Infection Model.

Ciprofloxacin Plus Erythromycin or Ambroxol Ameliorates Endotracheal Tube-Associated Pseudomonas Aeruginosa Biofilms in A Rat Model

Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus

In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin Against Escherichia Coli in a Neutropenic Murine Thigh Infection Model.

Antibacterial Effect Evaluation of Moxalactam Against Extended-Spectrum Beta-Lactamase-producing Escherichia Coli and Klebsiella Pneumoniae with in Vitro Pharmacokinetics/pharmacodynamics Simulation

Evaluation of the Antibacterial Effect in Vitro of Moxifloxacin and Linezolid on Nontuberculous Mycobacterium.

Application of palynological data to the chronology of the Palaeogene lava fields of the British Province: implications for magmatic stratigraphy

Immunomodulatory Effects and Protection in Sepsis by the Antibiotic Moxifloxacin

In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.

Continuous evaluation of single-dose moxifloxacin concentrations in brain extracellular fluid, cerebrospinal fluid, and plasma: a novel porcine model

Randomized Controlled Clinical Trial of Moxifloxacin Versus Levofloxacin Injection in the Treatment of Community Acquired Pneumonia

Fate of in vitro cultured Mycobacterium abscessus populations when exposed to moxifloxacin

Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection

Pharmacokinetic and pharmacodynamic analysis of flomoxef against the clinical isolates of strains

Implementation of the ACC/AHA Guidelines for Preoperative Cardiac Risk Assessment in a General Medicine Preoperative Clinic: Improving Efficiency and Preserving Outcomes

Improving image quality of x-ray in-line phase contrast imaging using an image restoration method.

Regioconvergent and Enantioselective Rhodium-Catalyzed Hydroamination of Internal and Terminal Alkynes: A Highly Flexible Access to Chiral Pyrazoles.

Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens

Eradication of Klebsiella pneumoniae pulmonary infection by silver oxytetracycline nano-structure

In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation